Security key
05338F306
Avalo Therapeutics, Inc. - COMMON STOCK (AVTX)
CUSIP: 05338F306
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 70,751,361
- Total 13F value
- $1,307,513,188
- Share change
- +39,935,663
- Put/Call ratio
- 80%
- SEC-reported price per share
- $18.48
- Number of holders
- 126
- Value change
- +$759,670,859
- Number of buys
- 103
- Number of sells
- 41
- Shares outstanding
- 53,624,847
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
126
Top holders
10
AVTX full security history
Ownership snapshot
Full 13F holder table
Avalo Therapeutics, Inc. SEC filings
Avalo Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of AVTX - Avalo Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Commodore Capital LP
Disclosed value leader
Commodore Capital LP
Comparable rows
15/15
Latest evidence
30 Jun 2026
13D/G
13F
Lead comparable stake: 9.9%
13D/G row: Commodore Capital LP
Showing 1-6 of 15 holder rows.
Quick read
Commodore Capital LP leads the comparable SEC ownership view at 9.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Commodore Capital LP's linked filing trail.
Comparable ownership
Top 5
Commodore Capital LP
9.9%
TCG Crossover GP II, LLC
7.9%
Deep Track Capital, LP
6.9%
BlackRock, Inc.
6.5%
RA CAPITAL MANAGEMENT, L.P.
6.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Commodore Capital LP |
13D/G
13F
Company
|
9.9%
|
$90,336,311
5,721,109 shares
|
$0 | 11 Jun 2026 |
| TCG Crossover GP II, LLC |
13D/G
|
7.9%
|
$43,476,699
3,017,120 shares
|
$0 | 05 May 2026 |
| Deep Track Capital, LP |
13D/G
|
6.9%
|
$69,348,100
3,610,000 shares
|
+$10,661,031 | 30 Jun 2026 |
| BlackRock, Inc. |
13D/G
13F
Company
|
6.5%
|
$63,122,709
3,415,731 shares
|
$0 | 30 Jun 2026 |
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
13F
Company
|
6.3%
|
$66,910,332
3,483,099 shares
|
+$19,737,199 | 30 Jun 2026 |
| Caligan Partners LP |
13D/G
13F
Company
|
5.9%
|
$60,777,866
3,163,866 shares
|
+$29,369,074 | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
126
Shares
70,751,361
Rows available
126
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
97
Q2 2026 holders
126
Holder diff
29
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|